nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketamine—PTGS1—Ifosfamide—germ cell cancer	0.125	0.18	CbGbCtD
Ketamine—CYP2B6—Ifosfamide—germ cell cancer	0.0952	0.137	CbGbCtD
Ketamine—CYP2C8—Ifosfamide—germ cell cancer	0.0721	0.104	CbGbCtD
Ketamine—PTGS1—Etoposide—germ cell cancer	0.0597	0.0858	CbGbCtD
Ketamine—CYP2C9—Ifosfamide—germ cell cancer	0.0503	0.0723	CbGbCtD
Ketamine—CYP2B6—Cisplatin—germ cell cancer	0.0463	0.0665	CbGbCtD
Ketamine—ABCB1—Dactinomycin—germ cell cancer	0.0413	0.0594	CbGbCtD
Ketamine—CYP2C8—Etoposide—germ cell cancer	0.0345	0.0495	CbGbCtD
Ketamine—CYP3A4—Ifosfamide—germ cell cancer	0.0292	0.042	CbGbCtD
Ketamine—ABCB1—Vinblastine—germ cell cancer	0.0259	0.0372	CbGbCtD
Ketamine—CYP2C9—Cisplatin—germ cell cancer	0.0245	0.0351	CbGbCtD
Ketamine—ABCB1—Cisplatin—germ cell cancer	0.0237	0.0341	CbGbCtD
Ketamine—ABCB1—Etoposide—germ cell cancer	0.0233	0.0335	CbGbCtD
Ketamine—CYP3A4—Vinblastine—germ cell cancer	0.0155	0.0223	CbGbCtD
Ketamine—ABCB1—Methotrexate—germ cell cancer	0.0154	0.0221	CbGbCtD
Ketamine—Clonus—Cisplatin—germ cell cancer	0.0141	0.179	CcSEcCtD
Ketamine—CYP3A4—Etoposide—germ cell cancer	0.014	0.0201	CbGbCtD
Ketamine—TACR1—trigeminal nerve—germ cell cancer	0.0118	0.0593	CbGeAlD
Ketamine—TACR1—vagus nerve—germ cell cancer	0.0111	0.0555	CbGeAlD
Ketamine—CYP2C9—cardial valve—germ cell cancer	0.00861	0.0431	CbGeAlD
Ketamine—TACR1—cranial nerve—germ cell cancer	0.00844	0.0423	CbGeAlD
Ketamine—GRIN1—telencephalic ventricle—germ cell cancer	0.00751	0.0376	CbGeAlD
Ketamine—GRIN2B—telencephalic ventricle—germ cell cancer	0.00716	0.0358	CbGeAlD
Ketamine—GRIN1—ganglion—germ cell cancer	0.00467	0.0234	CbGeAlD
Ketamine—GRIN2B—ganglion—germ cell cancer	0.00446	0.0223	CbGeAlD
Ketamine—TACR1—ganglion—germ cell cancer	0.00427	0.0214	CbGeAlD
Ketamine—Obstructive airways disorder—Methotrexate—germ cell cancer	0.00394	0.0499	CcSEcCtD
Ketamine—GRIN2A—ganglion—germ cell cancer	0.0039	0.0195	CbGeAlD
Ketamine—OPRM1—telencephalic ventricle—germ cell cancer	0.0038	0.019	CbGeAlD
Ketamine—Nystagmus—Vinblastine—germ cell cancer	0.00367	0.0464	CcSEcCtD
Ketamine—OPRD1—ganglion—germ cell cancer	0.00347	0.0174	CbGeAlD
Ketamine—GRIN3B—testis—germ cell cancer	0.00272	0.0136	CbGeAlD
Ketamine—DRD2—telencephalic ventricle—germ cell cancer	0.00254	0.0127	CbGeAlD
Ketamine—GRIN2C—brainstem—germ cell cancer	0.00245	0.0123	CbGeAlD
Ketamine—OPRM1—ganglion—germ cell cancer	0.00237	0.0119	CbGeAlD
Ketamine—GRIN2D—brainstem—germ cell cancer	0.00228	0.0114	CbGeAlD
Ketamine—GRIN2C—telencephalon—germ cell cancer	0.00218	0.0109	CbGeAlD
Ketamine—Cystitis noninfective—Bleomycin—germ cell cancer	0.00216	0.0274	CcSEcCtD
Ketamine—Cystitis—Bleomycin—germ cell cancer	0.00214	0.0271	CcSEcCtD
Ketamine—GRIN1—brainstem—germ cell cancer	0.00203	0.0102	CbGeAlD
Ketamine—GRIN2D—telencephalon—germ cell cancer	0.00202	0.0101	CbGeAlD
Ketamine—Bladder pain—Bleomycin—germ cell cancer	0.002	0.0253	CcSEcCtD
Ketamine—Laryngospasm—Etoposide—germ cell cancer	0.002	0.0253	CcSEcCtD
Ketamine—GRIN2B—brainstem—germ cell cancer	0.00194	0.0097	CbGeAlD
Ketamine—Muscle twitching—Ifosfamide—germ cell cancer	0.00193	0.0244	CcSEcCtD
Ketamine—GRIN3A—telencephalon—germ cell cancer	0.0019	0.00952	CbGeAlD
Ketamine—TACR1—brainstem—germ cell cancer	0.00186	0.0093	CbGeAlD
Ketamine—CYP2C9—urine—germ cell cancer	0.00186	0.00929	CbGeAlD
Ketamine—Salivary hypersecretion—Ifosfamide—germ cell cancer	0.00184	0.0233	CcSEcCtD
Ketamine—GRIN1—telencephalon—germ cell cancer	0.0018	0.00902	CbGeAlD
Ketamine—Apnoea—Etoposide—germ cell cancer	0.00176	0.0223	CcSEcCtD
Ketamine—SLC6A2—ganglion—germ cell cancer	0.00173	0.00868	CbGeAlD
Ketamine—GRIN2B—telencephalon—germ cell cancer	0.00172	0.00861	CbGeAlD
Ketamine—GRIN2C—medulla oblongata—germ cell cancer	0.00171	0.00855	CbGeAlD
Ketamine—GRIN2A—brainstem—germ cell cancer	0.00169	0.00848	CbGeAlD
Ketamine—TACR1—telencephalon—germ cell cancer	0.00165	0.00825	CbGeAlD
Ketamine—GRIN2D—medulla oblongata—germ cell cancer	0.00159	0.00795	CbGeAlD
Ketamine—DRD2—ganglion—germ cell cancer	0.00158	0.00791	CbGeAlD
Ketamine—GRIN2A—telencephalon—germ cell cancer	0.0015	0.00752	CbGeAlD
Ketamine—ABCB1—Abacavir transmembrane transport—SLC22A3—germ cell cancer	0.00149	0.0587	CbGpPWpGaD
Ketamine—GRIN2D—spinal cord—germ cell cancer	0.00142	0.00709	CbGeAlD
Ketamine—CYP3A4—urine—germ cell cancer	0.00142	0.00709	CbGeAlD
Ketamine—GRIN2C—head—germ cell cancer	0.00135	0.00678	CbGeAlD
Ketamine—OPRD1—telencephalon—germ cell cancer	0.00134	0.0067	CbGeAlD
Ketamine—GRIN2C—testis—germ cell cancer	0.00131	0.00655	CbGeAlD
Ketamine—GRIN1—midbrain—germ cell cancer	0.00129	0.00648	CbGeAlD
Ketamine—GRIN1—spinal cord—germ cell cancer	0.00126	0.00632	CbGeAlD
Ketamine—GRIN2D—head—germ cell cancer	0.00126	0.0063	CbGeAlD
Ketamine—GRIN2D—testis—germ cell cancer	0.00122	0.00609	CbGeAlD
Ketamine—GRIN2C—cerebellum—germ cell cancer	0.00121	0.00605	CbGeAlD
Ketamine—GRIN2B—spinal cord—germ cell cancer	0.0012	0.00603	CbGeAlD
Ketamine—TACR1—adrenal gland—germ cell cancer	0.0012	0.006	CbGeAlD
Ketamine—GRIN3A—head—germ cell cancer	0.00118	0.00593	CbGeAlD
Ketamine—GRIN2A—medulla oblongata—germ cell cancer	0.00118	0.00591	CbGeAlD
Ketamine—PTGS1—ganglion—germ cell cancer	0.00116	0.00578	CbGeAlD
Ketamine—TACR1—spinal cord—germ cell cancer	0.00116	0.00578	CbGeAlD
Ketamine—GRIN3A—testis—germ cell cancer	0.00114	0.00572	CbGeAlD
Ketamine—GRIN1—endocrine gland—germ cell cancer	0.00114	0.00569	CbGeAlD
Ketamine—GRIN2D—cerebellum—germ cell cancer	0.00112	0.00562	CbGeAlD
Ketamine—GRIN1—head—germ cell cancer	0.00112	0.00562	CbGeAlD
Ketamine—GRIN2A—adrenal gland—germ cell cancer	0.00109	0.00547	CbGeAlD
Ketamine—GRIN2B—endocrine gland—germ cell cancer	0.00108	0.00543	CbGeAlD
Ketamine—GRIN2A—midbrain—germ cell cancer	0.00108	0.0054	CbGeAlD
Ketamine—GRIN2B—head—germ cell cancer	0.00107	0.00536	CbGeAlD
Ketamine—Apnoea—Methotrexate—germ cell cancer	0.00106	0.0134	CcSEcCtD
Ketamine—GRIN2A—spinal cord—germ cell cancer	0.00105	0.00527	CbGeAlD
Ketamine—TACR1—endocrine gland—germ cell cancer	0.00104	0.0052	CbGeAlD
Ketamine—OPRM1—brainstem—germ cell cancer	0.00103	0.00515	CbGeAlD
Ketamine—TACR1—head—germ cell cancer	0.00103	0.00514	CbGeAlD
Ketamine—GRIN1—cerebellum—germ cell cancer	0.001	0.00501	CbGeAlD
Ketamine—PTGS1—endothelium—germ cell cancer	0.000996	0.00498	CbGeAlD
Ketamine—Convulsion—Vinblastine—germ cell cancer	0.000993	0.0126	CcSEcCtD
Ketamine—TACR1—testis—germ cell cancer	0.000992	0.00496	CbGeAlD
Ketamine—GRIN2C—brain—germ cell cancer	0.000982	0.00491	CbGeAlD
Ketamine—Erythema—Bleomycin—germ cell cancer	0.000968	0.0122	CcSEcCtD
Ketamine—Bradycardia—Ifosfamide—germ cell cancer	0.000967	0.0122	CcSEcCtD
Ketamine—GRIN2B—cerebellum—germ cell cancer	0.000955	0.00478	CbGeAlD
Ketamine—GRIN2A—endocrine gland—germ cell cancer	0.000948	0.00474	CbGeAlD
Ketamine—GRIN2A—head—germ cell cancer	0.000936	0.00468	CbGeAlD
Ketamine—PTGS1—blood vessel—germ cell cancer	0.000919	0.0046	CbGeAlD
Ketamine—OPRM1—telencephalon—germ cell cancer	0.000914	0.00457	CbGeAlD
Ketamine—GRIN2D—brain—germ cell cancer	0.000913	0.00457	CbGeAlD
Ketamine—GRIN2A—testis—germ cell cancer	0.000904	0.00452	CbGeAlD
Ketamine—Erythema—Dactinomycin—germ cell cancer	0.000902	0.0114	CcSEcCtD
Ketamine—Anorexia—Vinblastine—germ cell cancer	0.000891	0.0113	CcSEcCtD
Ketamine—Cystitis noninfective—Methotrexate—germ cell cancer	0.000874	0.0111	CcSEcCtD
Ketamine—Cystitis—Methotrexate—germ cell cancer	0.000864	0.0109	CcSEcCtD
Ketamine—GRIN3A—brain—germ cell cancer	0.000858	0.00429	CbGeAlD
Ketamine—ABCB1—Abacavir transport and metabolism—SLC22A3—germ cell cancer	0.000854	0.0337	CbGpPWpGaD
Ketamine—Arrhythmia—Ifosfamide—germ cell cancer	0.000849	0.0107	CcSEcCtD
Ketamine—GRIN2A—cerebellum—germ cell cancer	0.000835	0.00418	CbGeAlD
Ketamine—OPRD1—head—germ cell cancer	0.000834	0.00417	CbGeAlD
Ketamine—Bradycardia—Cisplatin—germ cell cancer	0.000834	0.0106	CcSEcCtD
Ketamine—Erythema—Ifosfamide—germ cell cancer	0.000827	0.0105	CcSEcCtD
Ketamine—GRIN1—brain—germ cell cancer	0.000813	0.00407	CbGeAlD
Ketamine—Decreased appetite—Vinblastine—germ cell cancer	0.000813	0.0103	CcSEcCtD
Ketamine—Bladder pain—Methotrexate—germ cell cancer	0.000809	0.0102	CcSEcCtD
Ketamine—OPRK1—head—germ cell cancer	0.0008	0.004	CbGeAlD
Ketamine—Pain—Vinblastine—germ cell cancer	0.0008	0.0101	CcSEcCtD
Ketamine—Anaphylactic shock—Bleomycin—germ cell cancer	0.00079	0.01	CcSEcCtD
Ketamine—Vision blurred—Ifosfamide—germ cell cancer	0.000779	0.00986	CcSEcCtD
Ketamine—GRIN2B—brain—germ cell cancer	0.000776	0.00388	CbGeAlD
Ketamine—SLC6A2—brainstem—germ cell cancer	0.000754	0.00377	CbGeAlD
Ketamine—Anorexia—Bleomycin—germ cell cancer	0.000753	0.00953	CcSEcCtD
Ketamine—TACR1—brain—germ cell cancer	0.000744	0.00372	CbGeAlD
Ketamine—Hypotension—Bleomycin—germ cell cancer	0.000738	0.00934	CcSEcCtD
Ketamine—Arrhythmia—Cisplatin—germ cell cancer	0.000732	0.00926	CcSEcCtD
Ketamine—TACR1—SIDS Susceptibility Pathways—NANOG—germ cell cancer	0.00072	0.0284	CbGpPWpGaD
Ketamine—TACR1—lymph node—germ cell cancer	0.000719	0.0036	CbGeAlD
Ketamine—Convulsion—Ifosfamide—germ cell cancer	0.000716	0.00907	CcSEcCtD
Ketamine—OPRK1—cerebellum—germ cell cancer	0.000713	0.00357	CbGeAlD
Ketamine—Erythema—Cisplatin—germ cell cancer	0.000713	0.00902	CcSEcCtD
Ketamine—SLC6A2—Monoamine Transport—PVRL2—germ cell cancer	0.000706	0.0279	CbGpPWpGaD
Ketamine—Anorexia—Dactinomycin—germ cell cancer	0.000702	0.00889	CcSEcCtD
Ketamine—TACR1—SIDS Susceptibility Pathways—POU5F1—germ cell cancer	0.000693	0.0274	CbGpPWpGaD
Ketamine—DRD2—brainstem—germ cell cancer	0.000687	0.00344	CbGeAlD
Ketamine—Decreased appetite—Bleomycin—germ cell cancer	0.000686	0.00869	CcSEcCtD
Ketamine—GRIN2A—brain—germ cell cancer	0.000678	0.00339	CbGeAlD
Ketamine—Pain—Bleomycin—germ cell cancer	0.000675	0.00855	CcSEcCtD
Ketamine—Anaphylactic shock—Ifosfamide—germ cell cancer	0.000675	0.00854	CcSEcCtD
Ketamine—Vision blurred—Cisplatin—germ cell cancer	0.000672	0.0085	CcSEcCtD
Ketamine—SLC6A2—telencephalon—germ cell cancer	0.000669	0.00335	CbGeAlD
Ketamine—DRD2—eye—germ cell cancer	0.000669	0.00335	CbGeAlD
Ketamine—DRD2—retina—germ cell cancer	0.000663	0.00332	CbGeAlD
Ketamine—OPRM1—midbrain—germ cell cancer	0.000656	0.00328	CbGeAlD
Ketamine—Anorexia—Ifosfamide—germ cell cancer	0.000643	0.00814	CcSEcCtD
Ketamine—Decreased appetite—Dactinomycin—germ cell cancer	0.00064	0.0081	CcSEcCtD
Ketamine—OPRM1—spinal cord—germ cell cancer	0.00064	0.0032	CbGeAlD
Ketamine—SLC6A2—decidua—germ cell cancer	0.000634	0.00317	CbGeAlD
Ketamine—Hypotension—Ifosfamide—germ cell cancer	0.000631	0.00798	CcSEcCtD
Ketamine—Pain—Dactinomycin—germ cell cancer	0.00063	0.00797	CcSEcCtD
Ketamine—Convulsion—Cisplatin—germ cell cancer	0.000618	0.00782	CcSEcCtD
Ketamine—DRD2—telencephalon—germ cell cancer	0.00061	0.00305	CbGeAlD
Ketamine—OPRD1—brain—germ cell cancer	0.000604	0.00303	CbGeAlD
Ketamine—Vomiting—Vinblastine—germ cell cancer	0.000594	0.00752	CcSEcCtD
Ketamine—Decreased appetite—Ifosfamide—germ cell cancer	0.000587	0.00743	CcSEcCtD
Ketamine—Anaphylactic shock—Cisplatin—germ cell cancer	0.000582	0.00736	CcSEcCtD
Ketamine—OPRK1—brain—germ cell cancer	0.00058	0.0029	CbGeAlD
Ketamine—Pain—Ifosfamide—germ cell cancer	0.000577	0.0073	CcSEcCtD
Ketamine—OPRM1—endocrine gland—germ cell cancer	0.000576	0.00288	CbGeAlD
Ketamine—OPRM1—head—germ cell cancer	0.000569	0.00285	CbGeAlD
Ketamine—Convulsion—Etoposide—germ cell cancer	0.000566	0.00716	CcSEcCtD
Ketamine—SLC6A2—gonad—germ cell cancer	0.000558	0.00279	CbGeAlD
Ketamine—Nausea—Vinblastine—germ cell cancer	0.000555	0.00703	CcSEcCtD
Ketamine—Anorexia—Cisplatin—germ cell cancer	0.000555	0.00702	CcSEcCtD
Ketamine—OPRM1—testis—germ cell cancer	0.00055	0.00275	CbGeAlD
Ketamine—Hypotension—Cisplatin—germ cell cancer	0.000544	0.00688	CcSEcCtD
Ketamine—ABCB1—blood vessel—germ cell cancer	0.000543	0.00272	CbGeAlD
Ketamine—Anaphylactic shock—Etoposide—germ cell cancer	0.000533	0.00675	CcSEcCtD
Ketamine—SLC6A2—medulla oblongata—germ cell cancer	0.000526	0.00263	CbGeAlD
Ketamine—Anorexia—Etoposide—germ cell cancer	0.000508	0.00643	CcSEcCtD
Ketamine—Decreased appetite—Cisplatin—germ cell cancer	0.000506	0.0064	CcSEcCtD
Ketamine—Vomiting—Bleomycin—germ cell cancer	0.000502	0.00636	CcSEcCtD
Ketamine—GRIN1—Mecp2 and Associated Rett Syndrome—FGF4—germ cell cancer	0.0005	0.0197	CbGpPWpGaD
Ketamine—Hypotension—Etoposide—germ cell cancer	0.000498	0.0063	CcSEcCtD
Ketamine—Rash—Bleomycin—germ cell cancer	0.000498	0.0063	CcSEcCtD
Ketamine—Pain—Cisplatin—germ cell cancer	0.000498	0.0063	CcSEcCtD
Ketamine—Dermatitis—Bleomycin—germ cell cancer	0.000497	0.0063	CcSEcCtD
Ketamine—GRIN1—SIDS Susceptibility Pathways—NANOG—germ cell cancer	0.000497	0.0196	CbGpPWpGaD
Ketamine—DRD2—pituitary gland—germ cell cancer	0.000496	0.00248	CbGeAlD
Ketamine—SLC6A2—adrenal gland—germ cell cancer	0.000487	0.00244	CbGeAlD
Ketamine—GRIN1—SIDS Susceptibility Pathways—POU5F1—germ cell cancer	0.000478	0.0189	CbGpPWpGaD
Ketamine—CYP2B6—skin of body—germ cell cancer	0.00047	0.00235	CbGeAlD
Ketamine—Nausea—Bleomycin—germ cell cancer	0.000469	0.00594	CcSEcCtD
Ketamine—Vomiting—Dactinomycin—germ cell cancer	0.000468	0.00593	CcSEcCtD
Ketamine—Rash—Dactinomycin—germ cell cancer	0.000464	0.00588	CcSEcCtD
Ketamine—Decreased appetite—Etoposide—germ cell cancer	0.000463	0.00586	CcSEcCtD
Ketamine—Pain—Etoposide—germ cell cancer	0.000456	0.00577	CcSEcCtD
Ketamine—CYP2C8—pituitary gland—germ cell cancer	0.000447	0.00224	CbGeAlD
Ketamine—PTGS1—telencephalon—germ cell cancer	0.000446	0.00223	CbGeAlD
Ketamine—CYP2B6—Metapathway biotransformation—NAT9—germ cell cancer	0.000438	0.0173	CbGpPWpGaD
Ketamine—DRD2—midbrain—germ cell cancer	0.000438	0.00219	CbGeAlD
Ketamine—Nausea—Dactinomycin—germ cell cancer	0.000437	0.00554	CcSEcCtD
Ketamine—Vomiting—Ifosfamide—germ cell cancer	0.000429	0.00543	CcSEcCtD
Ketamine—Rash—Ifosfamide—germ cell cancer	0.000426	0.00539	CcSEcCtD
Ketamine—PTGS1—skin of body—germ cell cancer	0.000425	0.00213	CbGeAlD
Ketamine—Dermatitis—Ifosfamide—germ cell cancer	0.000425	0.00538	CcSEcCtD
Ketamine—SLC6A2—endocrine gland—germ cell cancer	0.000422	0.00211	CbGeAlD
Ketamine—SLC6A2—head—germ cell cancer	0.000417	0.00208	CbGeAlD
Ketamine—OPRM1—brain—germ cell cancer	0.000412	0.00206	CbGeAlD
Ketamine—CYP2B6—gonad—germ cell cancer	0.000411	0.00206	CbGeAlD
Ketamine—SLC6A2—testis—germ cell cancer	0.000402	0.00201	CbGeAlD
Ketamine—Nausea—Ifosfamide—germ cell cancer	0.000401	0.00507	CcSEcCtD
Ketamine—Erythema—Methotrexate—germ cell cancer	0.000391	0.00495	CcSEcCtD
Ketamine—TACR1—SIDS Susceptibility Pathways—SOX2—germ cell cancer	0.000385	0.0152	CbGpPWpGaD
Ketamine—DRD2—endocrine gland—germ cell cancer	0.000384	0.00192	CbGeAlD
Ketamine—GRIN2C—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—germ cell cancer	0.000382	0.0151	CbGpPWpGaD
Ketamine—DRD2—head—germ cell cancer	0.00038	0.0019	CbGeAlD
Ketamine—CYP2C8—Metapathway biotransformation—NAT9—germ cell cancer	0.000371	0.0146	CbGpPWpGaD
Ketamine—Vomiting—Cisplatin—germ cell cancer	0.00037	0.00468	CcSEcCtD
Ketamine—PTGS1—uterus—germ cell cancer	0.000369	0.00185	CbGeAlD
Ketamine—Vision blurred—Methotrexate—germ cell cancer	0.000369	0.00467	CcSEcCtD
Ketamine—Rash—Cisplatin—germ cell cancer	0.000367	0.00464	CcSEcCtD
Ketamine—DRD2—testis—germ cell cancer	0.000367	0.00184	CbGeAlD
Ketamine—Dermatitis—Cisplatin—germ cell cancer	0.000366	0.00464	CcSEcCtD
Ketamine—PTGS1—pituitary gland—germ cell cancer	0.000363	0.00182	CbGeAlD
Ketamine—CYP2B6—adrenal gland—germ cell cancer	0.000359	0.00179	CbGeAlD
Ketamine—OPRK1—Mecp2 and Associated Rett Syndrome—FGF4—germ cell cancer	0.000358	0.0141	CbGpPWpGaD
Ketamine—GRIN2D—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—germ cell cancer	0.000355	0.014	CbGpPWpGaD
Ketamine—CYP2C8—endocrine gland—germ cell cancer	0.000347	0.00173	CbGeAlD
Ketamine—Nausea—Cisplatin—germ cell cancer	0.000346	0.00437	CcSEcCtD
Ketamine—Convulsion—Methotrexate—germ cell cancer	0.000339	0.00429	CcSEcCtD
Ketamine—Vomiting—Etoposide—germ cell cancer	0.000339	0.00429	CcSEcCtD
Ketamine—DRD2—cerebellum—germ cell cancer	0.000339	0.00169	CbGeAlD
Ketamine—Rash—Etoposide—germ cell cancer	0.000336	0.00425	CcSEcCtD
Ketamine—Dermatitis—Etoposide—germ cell cancer	0.000336	0.00425	CcSEcCtD
Ketamine—ABCB1—trigeminal ganglion—germ cell cancer	0.000335	0.00168	CbGeAlD
Ketamine—CYP2C8—testis—germ cell cancer	0.000331	0.00165	CbGeAlD
Ketamine—PTGS1—adrenal gland—germ cell cancer	0.000324	0.00162	CbGeAlD
Ketamine—ABCB1—embryo—germ cell cancer	0.000324	0.00162	CbGeAlD
Ketamine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.00032	0.0126	CbGpPWpGaD
Ketamine—Anaphylactic shock—Methotrexate—germ cell cancer	0.000319	0.00404	CcSEcCtD
Ketamine—Nausea—Etoposide—germ cell cancer	0.000317	0.00401	CcSEcCtD
Ketamine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.000315	0.0124	CbGpPWpGaD
Ketamine—PTGS1—spinal cord—germ cell cancer	0.000312	0.00156	CbGeAlD
Ketamine—CYP2B6—endocrine gland—germ cell cancer	0.000311	0.00156	CbGeAlD
Ketamine—CYP2C9—endocrine gland—germ cell cancer	0.000308	0.00154	CbGeAlD
Ketamine—CYP2B6—head—germ cell cancer	0.000307	0.00154	CbGeAlD
Ketamine—Anorexia—Methotrexate—germ cell cancer	0.000304	0.00385	CcSEcCtD
Ketamine—PTGS1—female gonad—germ cell cancer	0.000302	0.00151	CbGeAlD
Ketamine—CYP2C9—Metapathway biotransformation—NAT9—germ cell cancer	0.000302	0.0119	CbGpPWpGaD
Ketamine—SLC6A2—brain—germ cell cancer	0.000302	0.00151	CbGeAlD
Ketamine—Hypotension—Methotrexate—germ cell cancer	0.000298	0.00378	CcSEcCtD
Ketamine—CYP2B6—testis—germ cell cancer	0.000297	0.00148	CbGeAlD
Ketamine—SLC6A2—lymph node—germ cell cancer	0.000292	0.00146	CbGeAlD
Ketamine—GRIN2A—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—germ cell cancer	0.000291	0.0115	CbGpPWpGaD
Ketamine—ABCB1—retina—germ cell cancer	0.000286	0.00143	CbGeAlD
Ketamine—TACR1—G alpha (q) signalling events—OXT—germ cell cancer	0.000286	0.0113	CbGpPWpGaD
Ketamine—TACR1—Peptide ligand-binding receptors—OXT—germ cell cancer	0.000283	0.0112	CbGpPWpGaD
Ketamine—PTGS1—endocrine gland—germ cell cancer	0.000281	0.00141	CbGeAlD
Ketamine—Decreased appetite—Methotrexate—germ cell cancer	0.000278	0.00351	CcSEcCtD
Ketamine—PTGS1—head—germ cell cancer	0.000277	0.00139	CbGeAlD
Ketamine—DRD2—brain—germ cell cancer	0.000275	0.00138	CbGeAlD
Ketamine—GRIN1—BDNF signaling pathway—ALPL—germ cell cancer	0.000274	0.0108	CbGpPWpGaD
Ketamine—Pain—Methotrexate—germ cell cancer	0.000273	0.00346	CcSEcCtD
Ketamine—GRIN2C—CREB phosphorylation through the activation of Ras—HRAS—germ cell cancer	0.000272	0.0107	CbGpPWpGaD
Ketamine—PTGS1—testis—germ cell cancer	0.000268	0.00134	CbGeAlD
Ketamine—GRIN2B—BDNF signaling pathway—ALPL—germ cell cancer	0.000267	0.0105	CbGpPWpGaD
Ketamine—GRIN1—SIDS Susceptibility Pathways—SOX2—germ cell cancer	0.000265	0.0105	CbGpPWpGaD
Ketamine—ABCB1—telencephalon—germ cell cancer	0.000263	0.00132	CbGeAlD
Ketamine—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—OXT—germ cell cancer	0.000256	0.0101	CbGpPWpGaD
Ketamine—GRIN1—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—germ cell cancer	0.000254	0.01	CbGpPWpGaD
Ketamine—GRIN2D—CREB phosphorylation through the activation of Ras—HRAS—germ cell cancer	0.000253	0.00999	CbGpPWpGaD
Ketamine—ABCB1—decidua—germ cell cancer	0.00025	0.00125	CbGeAlD
Ketamine—CYP2C8—brain—germ cell cancer	0.000248	0.00124	CbGeAlD
Ketamine—GRIN2B—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—germ cell cancer	0.000248	0.00978	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—TDGF1—germ cell cancer	0.000242	0.00957	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—TDGF1—germ cell cancer	0.000236	0.00932	CbGpPWpGaD
Ketamine—CYP3A4—endocrine gland—germ cell cancer	0.000235	0.00117	CbGeAlD
Ketamine—SLC6A2—NRF2 pathway—SLC2A3—germ cell cancer	0.00023	0.0091	CbGpPWpGaD
Ketamine—TACR1—SIDS Susceptibility Pathways—AVP—germ cell cancer	0.000227	0.00895	CbGpPWpGaD
Ketamine—GRIN2C—Post NMDA receptor activation events—HRAS—germ cell cancer	0.000224	0.00884	CbGpPWpGaD
Ketamine—CYP2B6—brain—germ cell cancer	0.000222	0.00111	CbGeAlD
Ketamine—ABCB1—gonad—germ cell cancer	0.00022	0.0011	CbGeAlD
Ketamine—ABCB1—uterus—germ cell cancer	0.000218	0.00109	CbGeAlD
Ketamine—ABCB1—pituitary gland—germ cell cancer	0.000215	0.00107	CbGeAlD
Ketamine—GRIN2D—Post NMDA receptor activation events—HRAS—germ cell cancer	0.000208	0.00822	CbGpPWpGaD
Ketamine—GRIN2A—CREB phosphorylation through the activation of Ras—HRAS—germ cell cancer	0.000208	0.0082	CbGpPWpGaD
Ketamine—ABCB1—medulla oblongata—germ cell cancer	0.000207	0.00104	CbGeAlD
Ketamine—GRIN2C—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—germ cell cancer	0.000206	0.00814	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—SALL4—germ cell cancer	0.000206	0.00813	CbGpPWpGaD
Ketamine—Vomiting—Methotrexate—germ cell cancer	0.000203	0.00257	CcSEcCtD
Ketamine—Rash—Methotrexate—germ cell cancer	0.000201	0.00255	CcSEcCtD
Ketamine—Dermatitis—Methotrexate—germ cell cancer	0.000201	0.00255	CcSEcCtD
Ketamine—PTGS1—brain—germ cell cancer	0.000201	0.00101	CbGeAlD
Ketamine—GRIN2B—Developmental Biology—SALL4—germ cell cancer	0.000201	0.00793	CbGpPWpGaD
Ketamine—CYP3A4—Metapathway biotransformation—NAT9—germ cell cancer	0.000199	0.00786	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—NANOG—germ cell cancer	0.000198	0.0078	CbGpPWpGaD
Ketamine—TACR1—G alpha (q) signalling events—AVP—germ cell cancer	0.000196	0.00774	CbGpPWpGaD
Ketamine—PTGS1—lymph node—germ cell cancer	0.000194	0.000972	CbGeAlD
Ketamine—TACR1—Peptide ligand-binding receptors—AVP—germ cell cancer	0.000194	0.00764	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—NANOG—germ cell cancer	0.000193	0.0076	CbGpPWpGaD
Ketamine—GRIN2D—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—germ cell cancer	0.000192	0.00757	CbGpPWpGaD
Ketamine—ABCB1—adrenal gland—germ cell cancer	0.000192	0.000959	CbGeAlD
Ketamine—GRIN1—Developmental Biology—POU5F1—germ cell cancer	0.00019	0.00751	CbGpPWpGaD
Ketamine—Nausea—Methotrexate—germ cell cancer	0.00019	0.0024	CcSEcCtD
Ketamine—TACR1—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	0.000189	0.00748	CbGpPWpGaD
Ketamine—ABCB1—midbrain—germ cell cancer	0.000189	0.000947	CbGeAlD
Ketamine—ABCB1—bone marrow—germ cell cancer	0.000185	0.000928	CbGeAlD
Ketamine—GRIN2B—Developmental Biology—POU5F1—germ cell cancer	0.000185	0.00732	CbGpPWpGaD
Ketamine—ABCB1—spinal cord—germ cell cancer	0.000185	0.000924	CbGeAlD
Ketamine—GRIN1—CREB phosphorylation through the activation of Ras—HRAS—germ cell cancer	0.000181	0.00715	CbGpPWpGaD
Ketamine—ABCB1—female gonad—germ cell cancer	0.000179	0.000894	CbGeAlD
Ketamine—GRIN2B—CREB phosphorylation through the activation of Ras—HRAS—germ cell cancer	0.000177	0.00697	CbGpPWpGaD
Ketamine—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—germ cell cancer	0.000175	0.00692	CbGpPWpGaD
Ketamine—GRIN2A—Post NMDA receptor activation events—HRAS—germ cell cancer	0.000171	0.00675	CbGpPWpGaD
Ketamine—ABCB1—endocrine gland—germ cell cancer	0.000166	0.000832	CbGeAlD
Ketamine—ABCB1—head—germ cell cancer	0.000164	0.000821	CbGeAlD
Ketamine—OPRD1—Peptide ligand-binding receptors—OXT—germ cell cancer	0.000159	0.00628	CbGpPWpGaD
Ketamine—ABCB1—testis—germ cell cancer	0.000158	0.000793	CbGeAlD
Ketamine—GRIN2A—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—germ cell cancer	0.000157	0.00622	CbGpPWpGaD
Ketamine—GRIN1—SIDS Susceptibility Pathways—AVP—germ cell cancer	0.000156	0.00617	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—KLF4—germ cell cancer	0.00015	0.00591	CbGpPWpGaD
Ketamine—GRIN1—Post NMDA receptor activation events—HRAS—germ cell cancer	0.000149	0.00589	CbGpPWpGaD
Ketamine—ABCB1—cerebellum—germ cell cancer	0.000146	0.000733	CbGeAlD
Ketamine—GRIN2B—Developmental Biology—KLF4—germ cell cancer	0.000146	0.00576	CbGpPWpGaD
Ketamine—GRIN2B—Post NMDA receptor activation events—HRAS—germ cell cancer	0.000145	0.00574	CbGpPWpGaD
Ketamine—SLC6A2—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000145	0.00573	CbGpPWpGaD
Ketamine—TACR1—GPCR ligand binding—OXT—germ cell cancer	0.000144	0.0057	CbGpPWpGaD
Ketamine—SLC6A2—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000143	0.00565	CbGpPWpGaD
Ketamine—OPRK1—Peptide ligand-binding receptors—OXT—germ cell cancer	0.00014	0.00551	CbGpPWpGaD
Ketamine—GRIN1—EPHB-mediated forward signaling—HRAS—germ cell cancer	0.000137	0.00542	CbGpPWpGaD
Ketamine—GRIN1—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—germ cell cancer	0.000137	0.00542	CbGpPWpGaD
Ketamine—GRIN2B—EPHB-mediated forward signaling—HRAS—germ cell cancer	0.000134	0.00529	CbGpPWpGaD
Ketamine—GRIN2B—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—germ cell cancer	0.000134	0.00529	CbGpPWpGaD
Ketamine—TACR1—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	0.00013	0.00513	CbGpPWpGaD
Ketamine—GRIN2C—Alzheimers Disease—TP53—germ cell cancer	0.000128	0.00504	CbGpPWpGaD
Ketamine—ABCB1—brain—germ cell cancer	0.000119	0.000595	CbGeAlD
Ketamine—GRIN2D—Alzheimers Disease—TP53—germ cell cancer	0.000119	0.00468	CbGpPWpGaD
Ketamine—OPRM1—Peptide ligand-binding receptors—OXT—germ cell cancer	0.000118	0.00466	CbGpPWpGaD
Ketamine—ABCB1—lymph node—germ cell cancer	0.000115	0.000575	CbGeAlD
Ketamine—SLC6A2—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000113	0.00445	CbGpPWpGaD
Ketamine—OPRD1—Peptide ligand-binding receptors—AVP—germ cell cancer	0.000109	0.00431	CbGpPWpGaD
Ketamine—TACR1—Spinal Cord Injury—MYC—germ cell cancer	0.000109	0.0043	CbGpPWpGaD
Ketamine—OPRD1—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	0.000107	0.00421	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—SOX2—germ cell cancer	0.000105	0.00416	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—SOX2—germ cell cancer	0.000103	0.00406	CbGpPWpGaD
Ketamine—TACR1—GPCR ligand binding—AVP—germ cell cancer	9.89e-05	0.0039	CbGpPWpGaD
Ketamine—GRIN2A—Alzheimers Disease—TP53—germ cell cancer	9.74e-05	0.00385	CbGpPWpGaD
Ketamine—OPRK1—Peptide ligand-binding receptors—AVP—germ cell cancer	9.56e-05	0.00378	CbGpPWpGaD
Ketamine—OPRK1—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	9.36e-05	0.00369	CbGpPWpGaD
Ketamine—TACR1—Spinal Cord Injury—TP53—germ cell cancer	8.94e-05	0.00353	CbGpPWpGaD
Ketamine—GRIN1—Alzheimers Disease—TP53—germ cell cancer	8.5e-05	0.00336	CbGpPWpGaD
Ketamine—GRIN2B—Alzheimers Disease—TP53—germ cell cancer	8.28e-05	0.00327	CbGpPWpGaD
Ketamine—TACR1—GPCR downstream signaling—OXT—germ cell cancer	8.15e-05	0.00322	CbGpPWpGaD
Ketamine—OPRD1—GPCR ligand binding—OXT—germ cell cancer	8.13e-05	0.00321	CbGpPWpGaD
Ketamine—OPRM1—Peptide ligand-binding receptors—AVP—germ cell cancer	8.08e-05	0.00319	CbGpPWpGaD
Ketamine—OPRM1—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	7.91e-05	0.00312	CbGpPWpGaD
Ketamine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—germ cell cancer	7.83e-05	0.00309	CbGpPWpGaD
Ketamine—GRIN2C—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—germ cell cancer	7.72e-05	0.00305	CbGpPWpGaD
Ketamine—GRIN1—Spinal Cord Injury—MYC—germ cell cancer	7.51e-05	0.00296	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—OXT—germ cell cancer	7.41e-05	0.00292	CbGpPWpGaD
Ketamine—SLC6A2—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	7.38e-05	0.00291	CbGpPWpGaD
Ketamine—OPRD1—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	7.32e-05	0.00289	CbGpPWpGaD
Ketamine—SLC6A2—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	7.27e-05	0.00287	CbGpPWpGaD
Ketamine—GRIN2D—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—germ cell cancer	7.18e-05	0.00283	CbGpPWpGaD
Ketamine—OPRK1—GPCR ligand binding—OXT—germ cell cancer	7.13e-05	0.00281	CbGpPWpGaD
Ketamine—GRIN1—EPH-Ephrin signaling—HRAS—germ cell cancer	7.07e-05	0.00279	CbGpPWpGaD
Ketamine—GRIN2B—EPH-Ephrin signaling—HRAS—germ cell cancer	6.89e-05	0.00272	CbGpPWpGaD
Ketamine—SLC6A2—SLC-mediated transmembrane transport—AVP—germ cell cancer	6.7e-05	0.00264	CbGpPWpGaD
Ketamine—OPRK1—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	6.41e-05	0.00253	CbGpPWpGaD
Ketamine—GRIN1—Spinal Cord Injury—TP53—germ cell cancer	6.17e-05	0.00243	CbGpPWpGaD
Ketamine—OPRM1—GPCR ligand binding—OXT—germ cell cancer	6.02e-05	0.00238	CbGpPWpGaD
Ketamine—DRD2—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	5.99e-05	0.00237	CbGpPWpGaD
Ketamine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—germ cell cancer	5.9e-05	0.00233	CbGpPWpGaD
Ketamine—DRD2—Circadian rythm related genes—AVP—germ cell cancer	5.86e-05	0.00231	CbGpPWpGaD
Ketamine—GRIN2C—Transmission across Chemical Synapses—HRAS—germ cell cancer	5.81e-05	0.00229	CbGpPWpGaD
Ketamine—TACR1—GPCR downstream signaling—AVP—germ cell cancer	5.59e-05	0.00221	CbGpPWpGaD
Ketamine—OPRD1—GPCR ligand binding—AVP—germ cell cancer	5.57e-05	0.0022	CbGpPWpGaD
Ketamine—OPRM1—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	5.42e-05	0.00214	CbGpPWpGaD
Ketamine—GRIN2D—Transmission across Chemical Synapses—HRAS—germ cell cancer	5.4e-05	0.00213	CbGpPWpGaD
Ketamine—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—germ cell cancer	5.29e-05	0.00209	CbGpPWpGaD
Ketamine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—germ cell cancer	5.14e-05	0.00203	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—AVP—germ cell cancer	5.08e-05	0.002	CbGpPWpGaD
Ketamine—GRIN1—BDNF signaling pathway—HRAS—germ cell cancer	5.03e-05	0.00198	CbGpPWpGaD
Ketamine—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—germ cell cancer	5.01e-05	0.00198	CbGpPWpGaD
Ketamine—ABCB1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	4.97e-05	0.00196	CbGpPWpGaD
Ketamine—GRIN2B—BDNF signaling pathway—HRAS—germ cell cancer	4.9e-05	0.00193	CbGpPWpGaD
Ketamine—OPRK1—GPCR ligand binding—AVP—germ cell cancer	4.88e-05	0.00193	CbGpPWpGaD
Ketamine—PTGS1—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	4.88e-05	0.00193	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—OXT—germ cell cancer	4.59e-05	0.00181	CbGpPWpGaD
Ketamine—DRD2—GPCR ligand binding—OXT—germ cell cancer	4.56e-05	0.0018	CbGpPWpGaD
Ketamine—GRIN2C—Neuronal System—HRAS—germ cell cancer	4.45e-05	0.00176	CbGpPWpGaD
Ketamine—OPRM1—TCR Signaling Pathway—HRAS—germ cell cancer	4.43e-05	0.00175	CbGpPWpGaD
Ketamine—GRIN2A—Transmission across Chemical Synapses—HRAS—germ cell cancer	4.43e-05	0.00175	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—OXT—germ cell cancer	4.37e-05	0.00173	CbGpPWpGaD
Ketamine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—germ cell cancer	4.31e-05	0.0017	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—OXT—germ cell cancer	4.17e-05	0.00165	CbGpPWpGaD
Ketamine—GRIN2D—Neuronal System—HRAS—germ cell cancer	4.14e-05	0.00163	CbGpPWpGaD
Ketamine—OPRM1—GPCR ligand binding—AVP—germ cell cancer	4.13e-05	0.00163	CbGpPWpGaD
Ketamine—DRD2—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	4.11e-05	0.00162	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—OXT—germ cell cancer	4.03e-05	0.00159	CbGpPWpGaD
Ketamine—GRIN1—Transmission across Chemical Synapses—HRAS—germ cell cancer	3.87e-05	0.00153	CbGpPWpGaD
Ketamine—GRIN2B—Transmission across Chemical Synapses—HRAS—germ cell cancer	3.77e-05	0.00149	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—FGF4—germ cell cancer	3.73e-05	0.00147	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—OXT—germ cell cancer	3.66e-05	0.00144	CbGpPWpGaD
Ketamine—SLC6A2—Transmembrane transport of small molecules—AVP—germ cell cancer	3.4e-05	0.00134	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—OXT—germ cell cancer	3.4e-05	0.00134	CbGpPWpGaD
Ketamine—GRIN2A—Neuronal System—HRAS—germ cell cancer	3.4e-05	0.00134	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—H2AFZ—germ cell cancer	3.33e-05	0.00132	CbGpPWpGaD
Ketamine—ABCB1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	3.25e-05	0.00128	CbGpPWpGaD
Ketamine—ABCB1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	3.2e-05	0.00126	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	3.15e-05	0.00124	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—AVP—germ cell cancer	3.15e-05	0.00124	CbGpPWpGaD
Ketamine—DRD2—GPCR ligand binding—AVP—germ cell cancer	3.13e-05	0.00124	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—OXT—germ cell cancer	3.09e-05	0.00122	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—KITLG—germ cell cancer	3.07e-05	0.00121	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—AVP—germ cell cancer	3e-05	0.00118	CbGpPWpGaD
Ketamine—GRIN1—Neuronal System—HRAS—germ cell cancer	2.96e-05	0.00117	CbGpPWpGaD
Ketamine—GRIN2B—Neuronal System—HRAS—germ cell cancer	2.89e-05	0.00114	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—AVP—germ cell cancer	2.86e-05	0.00113	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—AVP—germ cell cancer	2.76e-05	0.00109	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—SLC2A3—germ cell cancer	2.71e-05	0.00107	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—SLC22A3—germ cell cancer	2.66e-05	0.00105	CbGpPWpGaD
Ketamine—GRIN1—Axon guidance—HRAS—germ cell cancer	2.63e-05	0.00104	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—OXT—germ cell cancer	2.58e-05	0.00102	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	2.56e-05	0.00101	CbGpPWpGaD
Ketamine—GRIN2B—Axon guidance—HRAS—germ cell cancer	2.56e-05	0.00101	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—AVP—germ cell cancer	2.51e-05	0.00099	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—OXT—germ cell cancer	2.46e-05	0.000973	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—OXT—germ cell cancer	2.34e-05	0.000925	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—AVP—germ cell cancer	2.33e-05	0.000921	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—FGFR3—germ cell cancer	2.28e-05	0.0009	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—CRABP1—germ cell cancer	2.17e-05	0.000858	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—OXT—germ cell cancer	2.16e-05	0.000853	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—AVP—germ cell cancer	2.12e-05	0.000836	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—FGF4—germ cell cancer	2.1e-05	0.00083	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—KIT—germ cell cancer	2.09e-05	0.000826	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—SLC2A3—germ cell cancer	2.06e-05	0.000815	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—SLC22A3—germ cell cancer	2.03e-05	0.000803	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—H2AFZ—germ cell cancer	1.88e-05	0.000741	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—HRAS—germ cell cancer	1.88e-05	0.00074	CbGpPWpGaD
Ketamine—DRD2—Circadian rythm related genes—TP53—germ cell cancer	1.85e-05	0.000729	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—FGF4—germ cell cancer	1.84e-05	0.000728	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—HRAS—germ cell cancer	1.83e-05	0.000722	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—OXT—germ cell cancer	1.83e-05	0.000721	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—AVP—germ cell cancer	1.77e-05	0.000698	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—SLC2A3—germ cell cancer	1.75e-05	0.00069	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—KITLG—germ cell cancer	1.73e-05	0.000682	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—SLC22A3—germ cell cancer	1.72e-05	0.00068	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—AVP—germ cell cancer	1.69e-05	0.000667	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—CRABP1—germ cell cancer	1.66e-05	0.000654	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—H2AFZ—germ cell cancer	1.65e-05	0.00065	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—AVP—germ cell cancer	1.61e-05	0.000634	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—FGF4—germ cell cancer	1.56e-05	0.000615	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—HRAS—germ cell cancer	1.53e-05	0.000605	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—SLC2A3—germ cell cancer	1.52e-05	0.000601	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—KITLG—germ cell cancer	1.52e-05	0.000598	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—SLC22A3—germ cell cancer	1.5e-05	0.000592	CbGpPWpGaD
Ketamine—ABCB1—Transmembrane transport of small molecules—AVP—germ cell cancer	1.5e-05	0.000592	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—AVP—germ cell cancer	1.48e-05	0.000585	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	1.45e-05	0.000573	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—SLC2A3—germ cell cancer	1.42e-05	0.000561	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—CRABP1—germ cell cancer	1.4e-05	0.000554	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—SLC22A3—germ cell cancer	1.4e-05	0.000553	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—H2AFZ—germ cell cancer	1.39e-05	0.000549	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—OXT—germ cell cancer	1.38e-05	0.000546	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—FGFR3—germ cell cancer	1.28e-05	0.000507	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—KITLG—germ cell cancer	1.28e-05	0.000505	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—AVP—germ cell cancer	1.25e-05	0.000494	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—CRABP1—germ cell cancer	1.22e-05	0.000483	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	1.19e-05	0.00047	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—FGF4—germ cell cancer	1.18e-05	0.000466	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—KIT—germ cell cancer	1.18e-05	0.000465	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—MYC—germ cell cancer	1.15e-05	0.000455	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—CRABP1—germ cell cancer	1.14e-05	0.000451	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—FGFR3—germ cell cancer	1.13e-05	0.000445	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—H2AFZ—germ cell cancer	1.05e-05	0.000416	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—KIT—germ cell cancer	1.03e-05	0.000408	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—KITLG—germ cell cancer	9.7e-06	0.000383	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—FGFR3—germ cell cancer	9.52e-06	0.000376	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—AVP—germ cell cancer	9.48e-06	0.000374	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—TP53—germ cell cancer	9.46e-06	0.000373	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—SLC2A3—germ cell cancer	9.38e-06	0.00037	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—SLC22A3—germ cell cancer	9.24e-06	0.000365	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—HRAS—germ cell cancer	9.05e-06	0.000357	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—KIT—germ cell cancer	8.74e-06	0.000345	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—HRAS—germ cell cancer	8.63e-06	0.00034	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—HRAS—germ cell cancer	7.56e-06	0.000299	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CRABP1—germ cell cancer	7.53e-06	0.000297	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—FGFR3—germ cell cancer	7.21e-06	0.000285	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—KIT—germ cell cancer	6.62e-06	0.000261	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—MYC—germ cell cancer	6.49e-06	0.000256	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—HRAS—germ cell cancer	6.39e-06	0.000252	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—MYC—germ cell cancer	5.69e-06	0.000225	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—TP53—germ cell cancer	5.33e-06	0.00021	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—HRAS—germ cell cancer	5.1e-06	0.000201	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—HRAS—germ cell cancer	4.84e-06	0.000191	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MYC—germ cell cancer	4.81e-06	0.00019	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—TP53—germ cell cancer	4.67e-06	0.000184	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—HRAS—germ cell cancer	4.47e-06	0.000176	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—TP53—germ cell cancer	3.95e-06	0.000156	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—HRAS—germ cell cancer	3.78e-06	0.000149	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MYC—germ cell cancer	3.64e-06	0.000144	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—TP53—germ cell cancer	2.99e-06	0.000118	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—HRAS—germ cell cancer	2.86e-06	0.000113	CbGpPWpGaD
